Abnormalities, Radiation-Induced: Clinical Trials

2 trials for Abnormalities, Radiation-Induced, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1

Follow Abnormalities, Radiation-Induced: new trials by email Literature Review of Abnormalities, Radiation-Induced trials Research Report on Abnormalities, Radiation-Induced

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Early Application of Memantine and Pioglitazone to Protect Cognitive Function After Radiotherapy
Memantine Oral Tablet, Pioglitazone 15mg, Hippocampal avoidance whole-brain radiotherapy (HA-WBRT) - Radiation Disease, Cognitive Impairment
Phase 2Not yet recruitingAffiliated Cancer Hospital & Institute of Guangzhou Medical University672024-09-102024-09-19
Evaluation of the Unstimulated Whole Saliva Flow During and After Radiotherapy, With the Use HcT20
Mouthrinse with HcT20 - Abnormalities, Radiation-Induced
Phase 2CompletedUPECLIN HC FM Botucatu Unesp312005-06-012009-04-01

Narrower conditions

Cognitive Dysfunction (1)  ·  Mouth Neoplasms (1)

Broader conditions

Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Radiation Injuries (2)  ·  Wounds and Injuries (2)  ·  Cognition Disorders (1)  ·  Head and Neck Neoplasms (1)  ·  Mental Disorders (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neurocognitive Disorders (1)  ·  Stomatognathic Diseases (1)

Interventions

Memantine (1)  ·  Pioglitazone (1)

Sponsors

Affiliated Cancer Hospital & Institute of Guangzhou Medical University (1)  ·  UPECLIN HC FM Botucatu Unesp (1)

Countries

Brazil (1)

Results publications

PMID 8324987